Open reading frame 3 of genotype 1 hepatitis e virus inhibits nuclear factor-κappa B signaling induced by tumor necrosis factor-α in human A549 lung epithelial cells

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Xu, Jian ^a   Wu, Fan ^a   Tian, Deying ^a   Wang, Jingjing ^a   Zheng, Zizheng ^b   Xia, Ningshao ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; BINDING PROTEIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P2; RECEPTOR INTERACTING PROTEIN 1; REGULATOR PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 3; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; NUCLEAR PROTEIN; ORF3 PROTEIN, HEPATITIS E VIRUS; SIGNAL PEPTIDE; TNFAIP3 PROTEIN, HUMAN; VIRUS PROTEIN;

ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; HEPATITIS E VIRUS; HEPATITIS E VIRUS GENOTYPE 1; HUMAN; HUMAN CELL; NONHUMAN; OPEN READING FRAME; OPEN READING FRAME 3; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE; UPREGULATION; CELL LINE; DRUG EFFECTS; ENZYME ACTIVATION; GENETICS; GENOTYPE; HEPATITIS E; LUNG; METABOLISM; PHOSPHORYLATION; VIROLOGY;

CELL LINE; DNA-BINDING PROTEINS; ENZYME ACTIVATION; EPITHELIAL CELLS; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG; NF-KAPPA B; NUCLEAR PROTEINS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UNFOLDED PROTEIN RESPONSE; VIRAL PROTEINS;

EID: 84903513669     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100787     Document Type: Article

References (53)

1. Perez-Gracia MT, Suay B, Mateos-Lindemann ML (2014) Hepatitis E: An emerging disease. Infect Genet Evol 22C: 40-59.
2. Scobie L, Dalton HR (2013) Hepatitis E: source and route of infection, clinical manifestations and new developments. J Viral Hepat 20: 1-11.
3. Mitsui T, Tsukamoto Y, Yamazaki C, Masuko K, Tsuda F, et al. (2004) Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion. J Med Virol 74: 563-572. (Pubitemid 39426097)
4. Teshale EH, Grytdal SP, Howard C, Barry V, Kamili S, et al. (2010) Evidence of person-to-person transmission of hepatitis E virus during a large outbreak in Northern Uganda. Clin Infect Dis 50: 1006-1010.
5. Khuroo MS, Kamili S (2009) Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers. J Viral Hepat 16: 519-523.
6. Schlosser B, Stein A, Neuhaus R, Pahl S, Ramez B, et al. (2012) Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J Hepatol 56: 500-502.
7. Yugo DM, Meng X-J (2013) Hepatitis E Virus: Foodborne, Waterborne and Zoonotic Transmission. International journal of environmental research and public health 10: 4507-4533.
8. Kumar A, Beniwal M, Kar P, Sharma JB, Murthy NS (2004) Hepatitis E in pregnancy. Int J Gynaecol Obstet 85: 240-244. (Pubitemid 38622553)
9. Motte A, Roquelaure B, Galambrun C, Bernard F, Zandotti C, et al. (2012) Hepatitis E in three immunocompromized children in southeastern France. J Clin Virol 53: 162-166.
10. Gonzalez Tallon AI, Moreira Vicente V, Mateos Lindemann ML, Achecar Justo LM (2011) [Chronic hepatitis E in an immunocompetent patient]. Gastroenterol Hepatol 34: 398-400.
11. Lu L, Li C, Hagedorn CH (2006) Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Reviews in medical virology 16: 5-36. (Pubitemid 43133591)
12. Hughes JM, Wilson ME, Teshale EH, Hu DJ, Holmberg SD (2010) The two faces of hepatitis E virus. Clinical infectious diseases 51: 328-334.
13. Holla RP, Ahmad I, Ahmad Z, Jameel S (2013) Molecular virology of hepatitis E virus. Semin Liver Dis 33: 3-14.
14. Ron D, Walter P (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8: 519-529. (Pubitemid 46985379)
15. Rehman S, Kapur N, Durgapal H, Panda SK (2008) Subcellular localization of hepatitis E virus (HEV) replicase. Virology 370: 77-92. (Pubitemid 350179904)
16. Ghosh S, Karin M (2002) Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl: S81-96.
17. Verhelst K, Carpentier I, Kreike M, Meloni L, Verstrepen L, et al. (2012) A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7. The EMBO journal 31: 3845-3855.
18. Li Q, Estepa G, Memet S, Israel A, Verma IM (2000) Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation. Genes Dev 14: 1729-1733. (Pubitemid 30602991)
19. Wagner S, Carpentier I, Rogov V, Kreike M, Ikeda F, et al. (2008) Ubiquitin binding mediates the NF-kappaB inhibitory potential of ABIN proteins. Oncogene 27: 3739-3745. (Pubitemid 351912974)
20. Pelzer C, Cabalzar K, Wolf A, Gonzalez M, Lenz G, et al. (2013) The protease activity of the paracaspase MALT1 is controlled by monoubiquitination. Nat Immunol 14: 337-345.
21. Aggarwal BB (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3: 745-756.
22. Tanaka T, Takahashi M, Kusano E, Okamoto H (2007) Development and evaluation of an efficient cell-culture system for Hepatitis E virus. J Gen Virol 88: 903-911. (Pubitemid 46359560)
23. Dong C, Zafrullah M, Mixson-Hayden T, Dai X, Liang J, et al. (2012) Suppression of interferon-alpha signaling by hepatitis E virus. Hepatology 55: 1324-1332.
24. Emerson S, Zhang M, Meng X-J, Nguyen H, Claire MS, et al. (2001) Recombinant hepatitis E virus genomes infectious for primates: importance of capping and discovery of a cis-reactive element. Proceedings of the National Academy of Sciences 98: 15270-15275. (Pubitemid 34014004)
25. Abmayr SM, Yao T, Parmely T, Workman JL (2006) Preparation of nuclear and cytoplasmic extracts from mammalian cells. Curr Protoc Mol Biol Chapter 12: Unit 12 11.
26. Kaufman RJ (1999) Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev 13: 1211-1233.
27. Fauquet CM, Mayo M, Maniloff J, Desselberger U, Ball LA (2005) Virus taxonomy: VIIIth report of the International Committee on Taxonomy of Viruses: Access Online via Elsevier.
28. Dalton HR, Bendall R, Ijaz S, Banks M (2008) Hepatitis E: an emerging infection in developed countries. The Lancet infectious diseases 8: 698-709.
29. Nagasaki F, Ueno Y, Kanno N, Okamoto H, Shimosegawa T (2005) A case of acute hepatitis with positive autoantibodies who actually had hepatitis E virus infection. Hepatology research 32: 134-137. (Pubitemid 40945774)
30. Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, et al. (2010) Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 376: 895-902.
31. Aggarwal R, Jameel S (2011) Hepatitis e. Hepatology 54: 2218-2226.
32. Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140: 805-820.
33. DiPerna G, Stack J, Bowie AG, Boyd A, Kotwal G, et al. (2004) Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors. J Biol Chem 279: 36570-36578. (Pubitemid 39129000)
34. Tai DI, Tsai SL, Chen YM, Chuang YL, Peng CY, et al. (2000) Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology 31: 656-664.
35. Roulston A, Lin R, Beauparlant P, Wainberg MA, Hiscott J (1995) Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors. Microbiological reviews 59: 481-505.
36. Chandra V, Taneja S, Kalia M, Jameel S (2008) Molecular biology and pathogenesis of hepatitis E virus. J Biosci 33: 451-464.
37. Chandra V, Kar-Roy A, Kumari S, Mayor S, Jameel S (2008) The hepatitis E virus ORF3 protein modulates epidermal growth factor receptor trafficking, STAT3 translocation, and the acute-phase response. J Virol 82: 7100-7110. (Pubitemid 351977728)
38. Kar-Roy A, Korkaya H, Oberoi R, Lal SK, Jameel S (2004) The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase. J Biol Chem 279: 28345-28357. (Pubitemid 38900114)
39. Elsharkawy AM, Mann DA (2007) Nuclear factor- kB and the hepatic inflammation-fibrosis-cancer axis. Hepatology 46: 590-597. (Pubitemid 47344795)
40. Karin M, Ben-Neriah Y (2000) Phosphorylation meets ubiquitination: the control of NF-κB activity. Annual review of immunology 18: 621-663. (Pubitemid 30365393)
41. Devhare PB, Chatterjee SN, Arankalle VA, Lole KS (2013) Analysis of Antiviral Response in Human Epithelial Cells Infected with Hepatitis E Virus. PloS one 8: e63793.
42. Shembade N, Harhaj EW (2012) Regulation of NF-kappaB signaling by the A20 deubiquitinase. Cell Mol Immunol 9: 123-130.
43. Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, et al. (2004) Deubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430: 694-699. (Pubitemid 39061687)
44. Harhaj EW, Dixit VM (2012) Regulation of NF-kappaB by deubiquitinases. Immunol Rev 246: 107-124.
45. Zhang K, Kaufman RJ (2008) From endoplasmic-reticulum stress to the inflammatory response. Nature 454: 455-462.
46. Parmar VM, Schroder M (2012) Sensing endoplasmic reticulum stress. Adv Exp Med Biol 738: 153-168.
47. Mori K (2009) Signalling pathways in the unfolded protein response: development from yeast to mammals. J Biochem 146: 743-750.
48. Kaneko M, Niinuma Y, Nomura Y (2003) Activation signal of nuclear factor-κB in response to endoplasmic reticulum stress is transduced via IRE1 and tumor necrosis factor receptor-associated factor 2. Biological and Pharmaceutical Bulletin 26: 931-935. (Pubitemid 41685414)
49. Nakajima S, Saito Y, Takahashi S, Hiramatsu N, Kato H, et al. (2010) Anti-inflammatory subtilase cytotoxin up-regulates A20 through the unfolded protein response. Biochem Biophys Res Commun 397: 176-180.
50. Carrara M, Prischi F, Ali MM (2013) UPR Signal Activation by Luminal Sensor Domains. Int J Mol Sci 14: 6454-6466.
51. Wang Y, Shen J, Arenzana N, Tirasophon W, Kaufman RJ, et al. (2000) Activation of ATF6 and an ATF6 DNA binding site by the endoplasmic reticulum stress response. J Biol Chem 275: 27013-27020.
52. Okada T, Haze K, Nadanaka S, Yoshida H, Seidah NG, et al. (2003) A serine protease inhibitor prevents endoplasmic reticulum stress-induced cleavage but not transport of the membrane-bound transcription factor ATF6. Journal of Biological Chemistry 278: 31024-31032. (Pubitemid 36994616)
53. Hosoi T, Hyoda K, Okuma Y, Nomura Y, Ozawa K (2007) Akt up-and downregulation in response to endoplasmic reticulum stress. Brain research 1152: 27-31. (Pubitemid 46802507)